This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Motor disorders
KRA_PSY_MOTOR
How to define "motor disorders"? Is there any details about this trait?
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
619 |
4. Check minimum number of eventsNone |
619 |
5. Include endpointsNone |
619 |
6. Filter based on genotype QC (FinnGen only) |
572 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F80-F89
- Name in latin
- Perturbatio specifica progressus functionis motoricae
Similar endpoints
↥List of similar endpoints to
Motor disorders
based on the number of shared cases.
Similar with more cases:
- Specific developmental disorder of motor function
- Motor disorders, excluding more controls
- Disorders of psychological development
- Any mental disorder
- Psychiatric diseases
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 572 | 240 | 332 |
| Unadjusted period prevalence (%) | 0.12 | 0.09 | 0.15 |
| Median age at first event (years) | 6.10 | 6.06 | 6.13 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 619
- Matched controls
- 6154
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F82
ICD-10 Finland
Specific developmental disorder of motor function
10116.2
307.7
583
6
F83
ICD-10 Finland
Mixed specific developmental disorders
11.8
141.8
167
187
R62.0
ICD-10 Finland
Delayed milestone
8.3
97.3
149
227
F80.1
ICD-10 Finland
Expressive language disorder
10.7
94.6
113
126
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
9.2
94.6
129
171
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
7.7
94.6
156
258
XA800
NOMESCO Finland
Neuropsychological investigation
7.3
94.3
167
298
R4120
NOMESCO Finland
Occupational therapy
7.0
75.8
133
232
Z2445
NOMESCO Finland
Psychologist
5.4
75.7
194
483
Z3226
NOMESCO Finland
Physiotherapist
4.2
64.9
260
904
F80.2
ICD-10 Finland
Receptive language disorder
9.2
63.5
82
100
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.7
62.4
183
502
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.4
52.6
66
77
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
8.3
50.3
70
93
R4110
NOMESCO Finland
Physiotherapy
3.4
44.9
246
1010
Z2446
NOMESCO Finland
Social worker
3.6
43.6
190
674
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.4
41.8
206
788
3154A
ICD-9 Finland
Specific delays in development, Coördination disorder
+∞
39.9
38
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.3
39.6
197
754
ZXE10
NOMESCO Finland
More than one and less than three hours
3.0
38.2
251
1127
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.5
38.0
170
608
Z2221
NOMESCO Finland
Medical doctor
3.1
37.7
236
1029
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
9.7
36.7
44
48
RT150, ,
NOMESCO Finland
7.9
36.3
52
71
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.6
36.3
95
232
Z3231
NOMESCO Finland
Registered nurse
2.8
35.5
304
1561
RL140, ,
NOMESCO Finland
8.7
35.3
46
56
Z3229
NOMESCO Finland
Other healthcare associate professional
3.7
33.9
125
392
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
33.6
159
584
F81.8
ICD-10 Finland
Other developmental disorders of scholastic skills
8.9
33.6
43
51
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
4.6
32.1
83
200
RT160, ,
NOMESCO Finland
8.5
31.7
42
52
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
5.0
31.7
74
164
N05AX08
ATC
risperidone; systemic
4.4
31.6
86
216
ZXD10
NOMESCO Finland
Scheduled procedure
2.7
31.5
281
1450
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.0
30.6
176
720
ZXE20
NOMESCO Finland
More than three and less than five hours
3.6
29.9
116
374
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
29.3
114
368
N05AH03
ATC
olanzapine; systemic
4.2
28.2
82
216
RL130, ,
NOMESCO Finland
7.4
28.1
42
60
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
7.5
27.7
41
58
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.5
27.3
109
357
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
27.2
96
290
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.8
26.8
65
148
602
Kela drug reimbursment
Children's severe malnutrition
4.6
25.7
64
149
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
25.6
203
970
R1260
NOMESCO Finland
Evaluation of communicative skills
7.1
25.1
39
58
ZY010
NOMESCO Finland
Hospital outpatient
3.1
25.0
119
433
R1250
NOMESCO Finland
Evaluation of functional capability
7.8
24.7
35
47
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
4.2
24.3
69
178
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.4
24.0
97
319
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.4
23.6
97
322
Z50.5
ICD-10 Finland
Speech therapy
3.8
23.6
80
234
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.9
23.3
73
202
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.4
23.1
62
153
F81.0
ICD-10 Finland
Specific reading disorder
6.0
22.5
41
72
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
7.7
22.5
32
43
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
6.6
22.3
37
59
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
3.1
21.9
104
376
ZXE00
NOMESCO Finland
One hour or less
2.3
21.5
287
1701
R5599
NOMESCO Finland
Other rehabilitation service
5.0
21.4
48
102
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.9
21.3
67
186
N05AX12
ATC
aripiprazole; systemic
3.8
21.2
70
201
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.8
20.5
48
106
Z31.5
ICD-10 Finland
Genetic counselling
3.2
20.4
90
311
F98.8
ICD-10 Finland
Other specified behavioural and emotional disorders with onset usually occurring in childhood and adolescence
6.3
20.4
35
58
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
5.3
19.9
41
81
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.7
19.7
67
196
F20.9
ICD-10 Finland
Schizophrenia, unspecified
8.0
19.5
27
35
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
19.5
133
582
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
19.2
82
278
P07.2
ICD-10 Finland
Extreme immaturity
23.3
19.2
27
12
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.9
18.7
101
391
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
7.9
18.7
26
34
N05AH02
ATC
clozapine; systemic
6.4
18.5
31
50
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
18.4
218
1214
N03AG01
ATC
valproic acid; systemic, rectal
3.5
18.1
65
197
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
17.9
143
672
ZXA00
NOMESCO Finland
Right side
2.7
17.6
105
428
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
17.6
129
583
A28
ICPC
Limited function/disability NOS
3.4
17.5
69
222
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
6.7
17.5
28
43
Z01.8
ICD-10 Finland
Other specified special examinations
2.4
17.4
147
708
P27.1
ICD-10 Finland
Bronchopulmonary dysplasia originating in the perinatal period
24.8
17.4
24
10
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
15.8
16.3
26
17
R4130
NOMESCO Finland
Speech therapy
3.7
16.0
53
152
H01AC01
ATC
somatropin; parenteral
3.8
15.6
50
140
F84.5
ICD-10 Finland
Asperger syndrome
5.2
15.3
32
64
RS222, ,
NOMESCO Finland
4.8
15.0
34
73
N05AH04
ATC
quetiapine; oral
2.3
15.0
136
672
N06BA04
ATC
methylphenidate; oral
2.4
14.8
118
551
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
14.7
204
1189
RF120, ,
NOMESCO Finland
11.2
14.6
27
25
WX722
NOMESCO Finland
PEEP
4.3
14.2
37
89
H52.2
ICD-10 Finland
Astigmatism
3.4
14.0
53
166
F88
ICD-10 Finland
Other disorders of psychological development
5.0
13.8
30
62
XX4AW, ,
NOMESCO Finland
3.9
13.8
41
109
K03.66
ICD-10 Finland
Tooth plaque
2.2
13.6
136
697
SPAT1229
SPAT
Assessment of need for aid
5.7
13.4
25
45
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
4.7
13.3
31
68
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
13.2
104
481
F93.9
ICD-10 Finland
Childhood emotional disorder, unspecified
4.8
13.1
30
65
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
5.6
13.1
25
46
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.8
13.1
68
257
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
5.2
12.9
27
54
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
5.2
12.9
27
54
N03AX14
ATC
levetiracetam; systemic
3.9
12.9
39
105
J45.1
ICD-10 Finland
Nonallergic asthma
2.5
12.8
92
409
R5140
NOMESCO Finland
Monitoring the use of the aid
4.5
12.6
31
71
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.5
12.6
88
385
183
Kela drug reimbursment
Lamotrigin and topiramate
5.6
12.6
24
44
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.0
12.4
59
212
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
5.0
12.4
27
56
N03AX09
ATC
lamotrigine; oral
3.2
12.3
50
164
WX882
NOMESCO Finland
High dependency care
2.5
12.2
87
385
H50.30
ICD-10 Finland
Intermittent esotropy
4.6
12.1
29
65
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.6
12.0
40
115
L02AE02
ATC
leuprorelin; implant, parenteral
10.3
12.0
23
23
FM2CE, ,
NOMESCO Finland
2.6
12.0
72
293
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.5
11.9
82
357
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
11.8
58
212
H50.0
ICD-10 Finland
Convergent concomitant strabismus
4.3
11.8
31
75
AA1AD
NOMESCO Finland
CT of head and brain
2.6
11.8
72
295
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.2
11.8
114
574
C03CA01
ATC
furosemide; systemic
3.5
11.7
42
127
RD210, ,
NOMESCO Finland
2.8
11.5
62
239
F93.89
ICD-10 Finland
Other childhood emotional disorders
3.2
11.4
47
155
N05AA02
ATC
levomepromazine; systemic
4.9
11.4
25
52
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.0
11.4
144
802
WX730
NOMESCO Finland
Conventional respirator
8.5
11.3
24
29
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.9
11.3
34
91
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.5
11.3
22
41
R11
ICD-10 Finland
Nausea and vomiting
2.3
11.3
94
445
ZXA05
NOMESCO Finland
Left side
2.3
11.2
89
412
RS211, ,
NOMESCO Finland
4.8
11.2
25
53
301
Kela drug reimbursment
Growth hormone
4.9
10.9
24
50
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
4.3
10.8
28
67
RT490, ,
NOMESCO Finland
5.7
10.7
20
36
RS220, ,
NOMESCO Finland
3.8
10.6
32
86
N05CD08
ATC
midazolam; nasal, systemic
3.3
10.5
40
126
N05BA09
ATC
clobazam; oral
4.0
10.4
30
78
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
8.4
10.3
22
27
ZYC01
NOMESCO Finland
Remote contact by phone
2.6
10.3
63
258
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.6
10.3
61
246
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
10.8
10.3
19
18
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
10.3
53
199
H35.1
ICD-10 Finland
Retinopathy of prematurity
19.1
10.3
15
8
F90.9
ICD-10 Finland
Hyperkinetic disorder, unspecified
3.3
10.2
38
118
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
10.2
115
613
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.4
10.1
72
317
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.5
10.0
35
104
ZXD20
NOMESCO Finland
Day surgery
2.4
10.0
73
325
P85
ICPC
Mental retardation
4.2
9.9
26
63
Z63.7
ICD-10 Finland
Other stressful life events affecting family and household
2.4
9.8
68
296
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.4
9.8
70
309
WX002
NOMESCO Finland
Sedation and analgesia
2.3
9.8
75
342
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.8
9.7
30
82
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
9.7
38
122
ZX108
NOMESCO Finland
Inhalation
5.1
9.5
20
40
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
15.2
9.5
15
10
H50.31
ICD-10 Finland
Intermittent exotropia
3.5
9.5
33
98
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
30.4
9.4
12
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.7
9.4
53
209
TPH07
NOMESCO Finland
Cathetrisation of artery
2.3
9.4
71
322
RF210, ,
NOMESCO Finland
4.4
9.3
23
53
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.2
9.3
85
417
F84.8
ICD-10 Finland
Other pervasive developmental disorders
5.0
9.3
20
41
SPAT1234
SPAT
Support of social functional capacity
4.0
9.1
26
67
IGY99
NOMESCO Finland
Other psychiatric treatment contact
2.4
9.1
68
306
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
2.6
9.1
52
206
ZXD05
NOMESCO Finland
Urgent procedure
1.8
9.1
150
908
F92.9
ICD-10 Finland
Mixed disorder of conduct and emotions, unspecified
4.7
9.0
21
46
RF420, ,
NOMESCO Finland
9.2
9.0
18
20
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
9.2
9.0
18
20
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.6
9.0
29
82
XCK00
NOMESCO Finland
Perimetry
4.4
8.9
22
51
ZXA10
NOMESCO Finland
Bilateral
2.0
8.8
115
644
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
8.7
64
286
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.4
8.7
61
267
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.1
8.7
37
125
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
4.3
8.6
22
52
BF20A, ,
NOMESCO Finland
16.5
8.6
13
8
T90
ICPC
Diabetes non-insulin dependent
3.3
8.5
32
100
RT422, ,
NOMESCO Finland
20.2
8.5
12
6
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.2
8.4
74
357
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
2.7
8.4
44
167
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.1
8.2
35
118
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.0
8.2
36
124
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
4.8
8.1
18
38
P07.02
ICD-10 Finland
Extremely low birth weight 750-999 g
33.6
8.1
10
*
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
8.1
22
55
RS312, ,
NOMESCO Finland
10.2
8.0
15
15
P07.01
ICD-10 Finland
Extremely low birth weight 500-749 g
22.2
8.0
11
5
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.5
7.9
52
221
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
13.2
7.9
13
10
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.6
7.8
26
75
N05BA01
ATC
diazepam; systemic, rectal
2.5
7.8
51
216
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
7.8
59
267
N03AF02
ATC
oxcarbazepine; oral
2.9
7.8
37
133
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
9.5
7.8
15
16
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
3.7
7.7
24
66
XG413
NOMESCO Finland
Spirometry with oscillometry
3.2
7.7
31
101
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
6.5
7.7
19
30
A03FA02
ATC
cisapride; oral, rectal
3.0
7.7
33
112
ZX114
NOMESCO Finland
Intramuscular
3.8
7.6
23
62
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
12.0
7.6
13
11
R27.0
ICD-10 Finland
Ataxia, unspecified
25.2
7.6
10
*
N05BA06
ATC
lorazepam; systemic, sublingual
6.3
7.6
19
31
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.1
7.5
32
108
P07.3
ICD-10 Finland
Other preterm infants
2.7
7.5
40
153
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.7
7.5
167
1096
EJC20
NOMESCO Finland
Operation on frenulum of tongue
3.7
7.5
23
63
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.6
7.4
24
68
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
80.6
7.4
8
*
ZX199
NOMESCO Finland
Other rote
4.5
7.4
18
41
Q38.1
ICD-10 Finland
Ankyloglossia
3.3
7.4
28
88
K07.24
ICD-10 Finland
Open bite
2.7
7.4
38
143
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
7.3
210
1471
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.9
7.3
34
121
F93.80
ICD-10 Finland
Generalized anxiety in the bardom age
11.0
7.3
13
12
E22.80
ICD-10 Finland
Central precocious puberty
11.0
7.3
13
12
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
+∞
7.3
7
*
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
2.5
7.3
46
192
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.3
7.3
27
84
UGC02
NOMESCO Finland
Rigid bronchoscopy
4.5
7.2
17
38
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
3.2
7.1
28
90
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
7.1
33
117
W0A12
NOMESCO Finland
Planned therapy visit for psychiatric disease
8.0
7.1
15
19
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
8.0
7.1
15
19
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.7
7.1
19
34
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
12.1
7.1
12
10
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.0
7.0
31
107
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
7.1
7.0
16
23
TJD20
NOMESCO Finland
Change of gastrostomy tube
4.3
7.0
18
43
N28
ICPC
Limited function/disability (N)
7.6
6.9
15
20
201
Kela drug reimbursment
Chronic cardiac insufficiency
3.8
6.9
21
57
F98.2
ICD-10 Finland
Feeding disorder of infancy and childhood
4.0
6.9
19
48
C03DA01
ATC
spironolactone; oral
2.9
6.9
32
114
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
4.2
6.8
18
44
F89
ICD-10 Finland
Unspecified disorder of psychological development
4.2
6.8
18
44
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.8
6.8
113
681
XF404
NOMESCO Finland
Ambulatory ECG
2.5
6.8
44
186
WX704
NOMESCO Finland
Intubation
2.5
6.8
43
180
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
6.7
39
156
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.7
6.7
152
998
EMB30
NOMESCO Finland
Adenotomy
1.8
6.7
121
746
Q04.8
ICD-10 Finland
Other specified congenital malformations of brain
22.7
6.7
9
*
N06AB10
ATC
escitalopram; oral
1.8
6.7
118
724
WX892
NOMESCO Finland
Monitored bed care
2.2
6.6
53
246
101
Kela drug reimbursment
Anterior pituitary hypofunction
3.1
6.6
27
89
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
3.8
6.6
20
54
SPAT1262
SPAT
Handing over of treatment supplies
2.2
6.6
56
266
WW804
NOMESCO Finland
Transfer from treating institution to higher-Level care, accompanied by doctor
6.0
6.6
17
29
N88
ICPC
Epilepsy
6.0
6.6
17
29
RF430, ,
NOMESCO Finland
12.3
6.6
11
9
J21.0
ICD-10 Finland
Acute bronchiolitis due to respiratory syncytial virus
2.6
6.6
37
146
205
Kela drug reimbursment
Chronic hypertension
3.3
6.6
24
74
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.3
6.5
49
221
H52.0
ICD-10 Finland
Hypermetropia
2.4
6.4
42
178
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
2.1
6.4
65
331
Z07
ICPC
Education problem
2.9
6.4
30
107
RT130, ,
NOMESCO Finland
7.5
6.4
14
19
ZX120
NOMESCO Finland
Intravenous
2.2
6.4
55
263
RS231, ,
NOMESCO Finland
14.4
6.4
10
7
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
6.4
50
230
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
4.1
6.3
17
42
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.3
6.3
48
218
G47.3
ICD-10 Finland
Sleep apnoea
2.3
6.3
48
218
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
6.3
35
137
H50.1
ICD-10 Finland
Divergent concomitant strabismus
5.6
6.3
17
31
B01AA03
ATC
warfarin; systemic
3.6
6.3
20
56
FDE00
NOMESCO Finland
Closure of patent ductus arteriosus
18.1
6.3
9
5
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
6.2
35
138
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
7.1
6.2
14
20
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
2.8
6.2
31
115
UKC02
NOMESCO Finland
Cystoscopy
2.9
6.2
29
104
Z71.8
ICD-10 Finland
Other specified counselling
1.6
6.2
214
1556
L28
ICPC
Limited function/disability (L)
2.3
6.2
47
214
RS120, ,
NOMESCO Finland
5.8
6.1
16
28
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
2.7
6.1
32
122
P07.10
ICD-10 Finland
Other low birth weight 1000-1499 g
12.6
6.1
10
8
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
6.0
31
117
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
335
2089
2.30
22.54
15.9
12.1
1.22
1.22
mmol/l
0.94
315
1927
324
2000
2.28
22.24
17.9
13.0
1.22
1.23
mmol/l
1.43
315
1905
382
2563
2.26
20.91
7.3
6.0
125.38
118.20
u/l
0.85
362
2417
282
1722
2.15
18.99
4.7
3.5
68.69
67.30
nmol/l
0.39
269
1633
29
48
6.25
16.86
14.6
16.4
18725.66
640.90
nmol/l
0.49
29
48
226
1381
1.99
14.19
9.6
8.5
37.87
38.11
g/l
0.26
213
1323
247
1577
1.93
13.48
9.3
7.9
23.12
20.32
umol/l
0.40
230
1456
513
4212
2.23
12.89
20.8
12.1
139.61
139.43
mmol/l
1.30
502
4082
177
1022
2.01
12.84
3.1
2.9
2.38
2.40
mmol/l
1.68
164
936
512
4215
2.20
12.54
20.6
12.1
3.96
3.93
mmol/l
1.00
500
4060
165
956
1.98
11.72
14.3
11.5
1.33
1.34
mmol/l
0.26
157
916
432
3412
1.86
11.06
4.5
3.4
14.66
14.51
pmol/l
0.60
401
3129
382
2920
1.79
10.76
11.5
10.2
0.21
0.22
e9/l
0.26
346
2472
148
861
1.93
10.23
1.8
1.5
98.64
99.61
pmol/l
0.09
71
445
63
260
2.57
10.17
19.4
15.5
-0.37
-0.09
mmol/l
0.18
50
213
473
3888
1.89
10.13
4.9
3.8
2.01
1.94
mu/l
0.85
448
3671
327
2426
1.72
9.89
11.0
7.6
5.85
6.08
mmol/l
1.37
311
2239
85
410
2.23
9.70
7.6
13.2
106.68
105.00
mmol/l
1.96
85
410
396
3108
1.74
9.67
14.5
11.3
3.64
3.56
e9/l
0.35
350
2603
530
4556
2.09
9.54
12.1
8.6
32.72
27.88
u/l
1.71
517
4404
168
1040
1.83
9.50
9.0
10.2
0.75
1.14
mmol/l
0.79
135
824
202
1325
1.77
9.39
5.4
4.7
40.90
35.04
u/l
0.43
196
1267
337
2546
1.69
9.32
4.5
3.2
36.60
36.36
mmol/mol
0.13
326
2429
116
641
1.98
9.24
16.7
13.1
0.80
0.81
mmol/l
0.35
110
615
144
858
1.87
9.16
4.1
3.8
4.44
1.94
e6/l
1.77
88
504
105
567
2.01
8.91
7.2
7.3
6.04
6.96
umol/l
0.29
91
469
151
922
1.83
8.85
3.2
3.0
1.02
1.02
kg/l
0.05
27
148
176
1132
1.76
8.64
4.1
4.8
7.93
8.83
mmol/l
1.14
161
1070
82
408
2.15
8.64
2.7
2.1
4.56
5.81
u/l
1.24
60
259
369
2912
1.64
8.16
3.8
2.3
5.74
5.39
mmol/l
3.17
346
2683
151
958
1.75
7.67
8.9
9.5
23.49
23.50
mmol/l
0.02
151
958
78
406
2.04
7.29
13.8
6.6
909.19
1353.21
ng/l
0.47
61
334
80
423
2.01
7.16
2.6
2.1
8.94
10.50
nmol/l
0.70
74
384
70
354
2.09
7.06
2.9
2.1
5.99
6.37
iu/l
0.17
51
222
134
844
1.74
6.92
4.2
3.7
0.54
0.59
e6/l
0.17
77
484
88
487
1.93
6.91
1.4
1.3
20.23
19.15
nmol/l
0.29
81
429
529
4683
1.85
6.75
23.6
14.9
13.98
13.33
%
3.10
523
4609
216
1549
1.59
6.71
5.7
4.5
—
—
—
0
0
374
3045
1.56
6.58
3.9
2.7
4.29
4.41
mmol/l
1.78
358
2922
354
2848
1.55
6.56
3.7
2.6
1.30
1.15
mmol/l
2.96
338
2719
99
579
1.83
6.54
3.8
3.0
2.58
2.57
g/l
0.08
88
559
151
1002
1.66
6.38
3.5
3.3
—
—
—
0
0
105
631
1.79
6.34
3.9
3.0
12.80
14.11
umol/l
1.04
96
615
355
2876
1.53
6.24
10.4
9.0
50.97
49.69
%
1.12
343
2779
150
1008
1.63
6.00
17.5
8.9
4.99
5.01
kpa
0.15
145
975
121
770
1.70
5.96
1.8
1.8
1.54
1.30
mmol/l
1.52
111
705
38
160
2.45
5.92
2.6
4.3
0.10
0.25
e6/l
0.64
38
154
368
3025
1.52
5.89
3.9
2.6
2.68
2.72
mmol/l
0.32
354
2870
358
2926
1.51
5.89
10.7
9.2
33.97
35.13
%
1.11
346
2826
149
1005
1.62
5.86
17.5
8.9
0.43
0.97
mmol/l
1.61
112
720
117
749
1.68
5.62
6.7
4.8
1.23
1.86
mg/l
0.88
87
512
91
545
1.77
5.54
5.1
3.4
780.66
1285.42
ng/l
0.67
58
287
339
2768
1.48
5.41
8.9
6.6
113.70
110.43
ml/min/173m2
1.90
231
1925
200
1468
1.52
5.39
5.5
4.3
10.93
44.00
e6/l
4.17
157
1128
362
3005
1.48
5.24
3.7
2.6
1.25
1.37
mmol/l
8.82
349
2863
41
189
2.24
5.24
25.9
17.6
92.51
95.65
%
0.70
41
189
89
541
1.74
5.15
4.2
3.1
19.54
22.56
%
1.47
84
519
148
1026
1.57
5.12
9.8
4.7
1.08
1.08
inr
0.05
29
303
33
141
2.40
5.01
3.3
3.7
10.58
9.57
%
0.25
33
141
110
719
1.63
4.85
9.6
7.4
31.05
31.10
s
0.03
110
711
34
150
2.33
4.82
14.9
12.1
22.41
23.20
mmol/l
0.91
34
142
40
190
2.17
4.77
26.3
17.6
0.59
0.72
%
1.45
40
190
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
102
2.60
4.72
27.1
26.5
0.32
0.33
u/ml
0.23
17
66
46
236
2.01
4.51
5.4
14.9
131.96
128.68
g/l
0.43
46
231
217
1674
1.44
4.39
4.2
3.3
—
—
—
0
0
132
928
1.53
4.23
17.0
8.7
9.69
9.82
kpa
0.32
126
899
69
414
1.74
4.18
2.5
1.9
—
—
—
0
0
182
1369
1.46
4.18
5.6
4.2
0.15
0.22
e6/l
0.50
136
1043
31
141
2.25
4.13
3.2
3.6
657.79
499.11
e6/l
0.66
24
100
31
142
2.23
4.06
3.2
3.6
0.28
0.19
e9/l
0.65
24
102
30
137
2.24
3.97
3.4
3.8
—
—
—
0
0
68
414
1.71
3.92
2.9
2.0
—
—
—
0
0
85
549
1.63
3.92
1.5
1.4
225.11
420.74
u/ml
0.92
79
522
65
392
1.72
3.88
13.4
10.4
92.32
91.43
%
0.13
65
392
41
214
1.97
3.86
4.7
3.7
—
—
—
0
0
482
5163
0.68
3.81
3.8
3.9
—
—
—
0
0
99
672
1.55
3.70
2.2
1.7
1.72
1.39
%
0.61
92
617
308
2588
1.36
3.58
5.3
3.8
163.40
178.08
e6/l
—
10
24
36
185
1.99
3.55
2.3
4.8
270.69
403.78
mg/l
1.57
36
180
28
131
2.18
3.52
3.4
3.7
20.89
25.08
%
1.13
28
131
31
153
2.07
3.41
5.1
8.4
24.18
24.21
mmol/l
0.02
31
145
28
133
2.14
3.40
3.3
2.2
—
—
—
0
0
28
133
2.14
3.40
3.3
2.2
—
—
—
0
0
8
238
0.33
3.38
1.5
1.7
—
—
—
0
0
62
384
1.67
3.37
2.2
2.7
23.22
31.26
u/l
2.33
51
323
25
114
2.23
3.35
2.4
1.6
—
—
—
0
0
591
5619
2.01
3.34
25.6
15.5
267.19
266.52
e9/l
0.09
574
5373
591
5622
2.00
3.29
26.9
16.2
40.40
41.09
%
0.38
570
5405
36
191
1.93
3.26
2.0
1.4
—
—
—
0
0
13
43
3.05
3.23
2.8
2.3
—
—
—
0
0
591
5629
1.97
3.16
25.5
15.3
4.72
4.69
e12/l
0.99
570
5372
131
974
1.43
3.12
4.5
3.4
7.32
6.40
e6/l
0.28
118
876
34
180
1.93
3.11
2.4
5.0
8.88
5.50
e6/l
0.19
25
123
34
180
1.93
3.11
2.5
5.0
34.63
310.54
e6/l
1.34
27
126
33
173
1.95
3.10
12.3
11.2
1135.40
392.65
iu/ml
—
5
23
23
105
2.22
3.08
2.7
3.2
1041.09
802.30
e6/l
0.73
23
105
33
174
1.94
3.06
3.9
2.2
—
—
—
0
0
26
126
2.10
3.02
1.7
1.5
5.80
7.46
ug/l
0.30
26
118
8
223
0.35
2.98
1.4
1.5
—
—
—
0
0
33
176
1.91
2.96
2.2
4.9
3.23
3.34
mmol/l
0.54
33
169
193
2331
0.74
2.93
1.9
2.0
—
—
—
0
0
25
122
2.08
2.87
3.1
2.0
—
—
—
0
0
26
129
2.05
2.86
2.5
2.1
—
—
—
0
0
81
558
1.51
2.84
2.7
2.0
—
—
—
0
0
11
33
3.35
2.80
1.2
1.2
—
—
—
0
0
237
1967
1.32
2.80
4.0
3.4
0.00
0.00
estimate
-0.00
26
370
21
98
2.17
2.70
4.3
4.5
23.43
24.89
umol/l
0.33
21
98
12
40
3.02
2.68
7.7
9.4
—
—
—
0
0
31
169
1.87
2.63
3.5
2.1
—
—
—
0
0
23
113
2.06
2.61
1.6
1.4
—
—
—
0
0
9
25
3.62
2.56
3.2
3.8
—
—
—
0
0
12
44
2.75
2.53
2.8
2.4
37535.17
40309.09
ug/l
0.24
12
44
42
255
1.68
2.51
1.5
1.5
990.59
1104.08
nmol/l
0.35
32
205
234
1963
1.30
2.49
5.7
4.9
0.00
0.00
estimate
-0.00
27
382
518
4834
1.40
2.48
16.5
10.6
22.50
22.57
mg/l
0.01
394
3307
34
195
1.78
2.47
1.6
1.7
—
—
—
0
0
92
669
1.43
2.47
3.0
2.2
70.39
36.23
ng/l
0.48
48
243
28
151
1.88
2.47
3.4
2.1
—
—
—
0
0
28
151
1.88
2.47
3.4
2.1
—
—
—
0
0
299
2593
1.28
2.45
5.7
4.0
36.01
28.41
u/l
1.67
292
2490
53
344
1.58
2.44
2.4
2.1
2.41
2.41
mmol/l
0.01
41
293
13
51
2.57
2.43
2.2
1.7
20.80
19.81
nmol/l
—
5
16
6
12
5.01
2.39
3.7
1.3
—
—
—
0
0
34
198
1.75
2.36
3.7
3.0
14.09
22.21
mu/l
1.16
34
190
124
960
1.36
2.30
3.7
3.6
0.00
0.00
estimate
0.50
27
364
233
1976
1.28
2.23
4.1
3.4
0.00
0.00
estimate
-0.00
27
372
21
107
1.98
2.19
1.5
1.4
—
—
—
0
0
28
158
1.80
2.17
2.1
3.5
85.21
92.76
ml/min/173m2
—
7
46
11
250
0.43
2.17
1.5
1.6
—
—
—
0
0
33
196
1.71
2.16
5.2
15.2
0.68
0.65
%
0.11
33
196
9
30
3.01
2.14
3.1
5.8
167.56
205.26
ug/l
—
9
30
48
315
1.56
2.14
2.3
1.9
—
—
—
0
0
10
37
2.71
2.06
26.1
6.9
1.21
1.24
mmol/l
—
10
31
22
117
1.90
2.05
2.7
2.1
—
—
—
0
0
22
381
0.56
1.97
1.1
1.2
—
—
—
0
0
15
70
2.16
1.97
1.6
1.3
8.11
3.75
u/ml
—
9
32
13
57
2.29
1.96
7.9
7.5
2.23
2.39
mg/l
—
8
47
18
91
2.00
1.94
3.8
2.6
1.54
2.03
mmol/l
—
10
76
58
409
1.45
1.86
1.6
1.3
137.80
139.32
iu/ml
0.01
12
136
20
107
1.89
1.85
5.7
6.1
2.60
1.92
ug/l
0.54
20
107
17
309
0.53
1.81
1.7
1.8
—
—
—
0
0
15
73
2.07
1.79
17.9
9.8
9.27
8.89
mg/l
0.08
15
67
22
123
1.81
1.79
1.3
1.4
328.13
385.98
ug/g
0.80
15
64
60
430
1.43
1.78
3.7
4.5
4.75
50.47
mg/mmol
0.78
41
342
13
60
2.18
1.76
1.1
1.1
—
—
—
0
0
14
67
2.10
1.74
5.0
5.7
—
—
—
0
0
16
81
1.99
1.73
39.3
35.2
154.62
146.76
ug/l
0.12
16
76
9
36
2.51
1.73
1.4
1.1
72.67
75.58
%
—
9
36
9
36
2.51
1.73
1.4
1.1
651.33
375.73
mu/l
—
9
36
12
54
2.23
1.72
1.5
1.2
—
—
—
0
0
35
519
0.65
1.70
1.4
1.5
—
—
—
0
0
11
48
2.30
1.69
2.5
4.9
18.19
24.35
ug/l
1.29
11
48
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
62
2.11
1.64
1.5
1.2
—
—
—
0
0
7
25
2.80
1.64
2.0
2.3
—
—
—
0
0
11
49
2.25
1.62
5.5
7.2
—
—
—
0
0
11
49
2.25
1.62
6.4
7.5
—
—
—
0
0
11
50
2.21
1.55
3.1
1.6
—
—
—
0
0
328
2971
1.21
1.55
5.2
4.2
8.13
7.14
mm/h
0.90
311
2759
16
85
1.89
1.54
2.6
1.5
—
—
—
0
0
13
64
2.04
1.53
1.1
1.0
—
—
—
0
0
6
21
2.86
1.50
2.2
2.6
—
—
—
0
0
140
1170
1.25
1.46
3.8
3.1
2.76
2.60
mg/l
0.45
127
1036
12
59
2.04
1.42
1.0
1.1
—
—
—
0
0
34
485
0.68
1.39
1.5
1.5
—
—
—
0
0
10
46
2.18
1.38
1.0
1.0
—
—
—
0
0
7
29
2.42
1.38
4.6
2.2
13.04
18.27
umol/l
—
7
29
23
142
1.63
1.37
2.2
1.8
—
—
—
0
0
12
60
2.01
1.37
8.9
9.6
—
—
—
0
0
12
60
2.01
1.37
1.5
1.2
—
—
—
0
0
29
190
1.54
1.37
1.4
1.1
—
—
—
0
0
157
1344
1.22
1.30
3.4
3.1
—
—
—
0
0
8
34
2.36
1.29
1.0
1.1
—
—
—
0
0
217
1919
1.19
1.27
1.9
1.7
1.66
1.65
g/l
0.03
114
1009
53
397
1.36
1.27
9.5
7.2
253.26
310.86
u/l
1.36
53
390
15
84
1.79
1.26
1.1
1.1
—
—
—
0
0
249
2231
1.18
1.25
3.9
3.2
65.24
59.08
ug/l
0.32
240
2115
6
25
2.40
1.23
1.0
1.6
—
—
—
0
0
8
37
2.16
1.21
2.0
1.2
—
—
—
0
0
10
50
2.00
1.15
1.2
1.1
—
—
—
0
0
18
110
1.65
1.14
2.9
1.6
—
—
—
0
0
136
1558
0.83
1.13
2.7
2.6
—
—
—
0
0
31
218
1.44
1.08
3.2
1.9
30.38
31.48
%
0.20
21
170
5
21
2.38
1.08
1.2
1.6
—
—
—
0
0
5
107
0.46
1.02
4.6
4.0
2.43
3.13
e9/l
—
5
107
13
75
1.74
1.01
3.1
3.6
17.54
18.18
%
—
7
47
12
68
1.77
0.99
3.0
1.6
—
—
—
0
0
19
123
1.55
0.98
5.6
20.9
77.83
72.70
%
0.74
19
123
9
51
1.77
0.94
1.7
2.0
—
—
—
0
0
13
207
0.62
0.94
1.0
1.1
—
8.26
—
0
28
6
27
2.22
0.93
1.0
2.1
10.52
10.03
g/l
—
6
27
6
29
2.07
0.89
2.2
1.2
—
—
—
0
0
8
42
1.91
0.88
3.4
1.6
—
—
—
0
0
129
1452
0.85
0.87
2.4
2.4
—
—
—
0
0
6
30
2.00
0.86
1.0
2.0
7.63
7.42
g/l
—
6
30
6
30
2.00
0.86
1.0
2.0
—
—
—
0
0
6
30
2.00
0.86
1.0
2.0
3.37
3.53
g/l
—
6
30
6
30
2.00
0.86
1.0
2.0
2.65
3.11
g/l
—
6
30
6
114
0.52
0.83
1.7
1.9
—
—
—
0
0
6
32
1.87
0.81
1.3
1.4
—
—
—
0
0
6
32
1.87
0.81
1.3
1.4
—
—
—
0
0
6
32
1.87
0.81
1.3
1.4
—
—
—
0
0
36
276
1.32
0.80
1.1
1.2
—
29.43
—
0
9
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
14
90
1.56
0.77
1.4
1.7
125.43
207.90
pmol/l
1.43
14
90
27
355
0.75
0.76
1.4
1.3
—
—
—
0
0
6
108
0.55
0.73
7.7
4.2
42.83
49.59
%
—
6
108
16
108
1.49
0.72
2.4
2.0
2.42
6.41
iu/l
—
6
39
29
219
1.33
0.72
2.4
2.0
—
—
—
0
0
24
176
1.37
0.71
1.4
1.4
—
—
—
0
0
24
176
1.37
0.71
1.4
1.4
—
—
—
0
0
13
84
1.55
0.71
2.9
1.7
—
—
—
0
0
5
26
1.92
0.70
1.0
2.1
0.00
0.00
g/l
—
5
26
5
26
1.92
0.70
1.0
2.1
0.00
0.00
g/l
—
5
26
5
27
1.85
0.68
1.0
2.1
40.54
41.17
g/l
—
5
27
7
42
1.66
0.68
1.1
1.1
—
—
—
0
0
5
28
1.78
0.66
1.0
1.5
—
—
—
0
0
30
378
0.78
0.64
1.3
1.4
—
—
—
0
0
5
29
1.72
0.63
1.0
2.1
0.00
0.00
g/l
—
5
29
5
29
1.72
0.63
1.0
2.1
0.00
0.16
g/l
—
5
29
5
30
1.66
0.61
1.0
1.0
2497.40
1732.40
miu/ml
—
5
30
36
289
1.25
0.60
2.8
2.2
—
87.35
—
0
26
55
463
1.20
0.59
2.7
2.6
7591.77
4224.96
u/l
0.24
13
169
37
299
1.24
0.58
1.9
2.2
—
14.95
—
0
23
30
368
0.80
0.53
1.2
1.2
—
—
—
0
0
7
47
1.49
0.47
1.3
1.7
8.41
7.00
mmol/l
—
7
42
14
186
0.74
0.46
1.9
1.5
0.00
0.09
iu/ml
—
7
45
5
84
0.59
0.45
1.6
1.6
—
—
—
0
0
216
2031
1.09
0.44
1.6
1.8
0.43
3.42
u/ml
5.87
39
362
8
56
1.43
0.42
2.4
1.3
—
—
—
0
0
43
494
0.86
0.42
1.2
1.2
12.91
15.21
iu/ml
—
9
105
8
58
1.38
0.41
1.1
1.2
—
—
—
0
0
5
34
1.47
0.40
2.8
1.8
—
—
—
0
0
15
115
1.30
0.38
4.0
4.6
8.11
16.90
u/ml
0.51
15
115
9
69
1.30
0.37
1.1
1.2
—
—
—
0
0
5
80
0.62
0.35
1.6
1.2
—
—
—
0
0
9
125
0.71
0.35
1.7
1.9
—
—
—
0
0
6
43
1.39
0.35
1.3
1.2
—
—
—
0
0
6
44
1.36
0.34
1.3
1.2
—
—
—
0
0
6
44
1.36
0.34
1.3
1.4
—
—
—
0
0
10
73
1.37
0.33
1.4
1.4
—
—
—
0
0
42
472
0.88
0.32
1.2
1.2
0.92
5.40
u/ml
2.08
14
147
20
239
0.83
0.31
3.3
2.2
—
—
—
0
0
17
205
0.82
0.29
2.1
1.9
—
—
—
0
0
25
212
1.18
0.29
1.0
1.0
9.67
9.24
mu/l
0.12
19
181
28
320
0.86
0.28
1.8
1.9
—
—
—
0
0
13
160
0.80
0.27
1.6
1.1
—
—
—
0
0
5
74
0.67
0.26
1.0
1.1
—
—
—
0
0
18
212
0.84
0.25
1.1
1.1
—
—
—
0
0
12
96
1.25
0.23
2.0
2.4
—
—
—
0
0
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
5
38
1.31
0.23
1.0
1.3
—
—
—
0
0
15
124
1.21
0.23
1.8
1.7
—
—
—
0
0
5
40
1.24
0.22
1.0
1.3
—
—
—
0
0
5
40
1.24
0.22
1.0
1.3
—
—
—
0
0
21
240
0.87
0.22
1.0
1.1
0.77
0.50
u/ml
—
10
130
0
10
0.00
0.21
0.0
1.4
—
1.44
—
0
10
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
10
123
0.81
0.21
1.0
1.8
—
—
—
0
0
13
155
0.83
0.21
1.6
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
9.81
—
0
12
8
104
0.76
0.21
1.3
1.2
—
—
—
0
0
41
446
0.91
0.21
1.1
1.2
4.63
6.55
u/ml
0.41
27
344
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
29
322
0.89
0.20
1.4
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
40
434
0.91
0.19
1.1
1.2
4.85
3.13
u/ml
0.33
29
333
12
142
0.84
0.18
1.2
1.4
52.37
17.67
u/ml
—
7
119
16
184
0.86
0.18
1.4
1.3
—
—
—
0
0
41
441
0.92
0.17
1.1
1.2
1.69
1.28
u/ml
0.17
27
324
5
65
0.76
0.17
7.4
4.5
—
—
—
0
0
5
65
0.76
0.17
7.4
4.5
—
—
—
0
0
5
69
0.72
0.17
1.8
1.6
—
—
—
0
0
8
68
1.17
0.16
1.3
1.1
—
—
—
0
0
16
138
1.16
0.16
4.7
3.0
—
—
—
0
0
6
77
0.77
0.15
1.0
1.2
—
—
—
0
0
22
240
0.91
0.12
1.5
1.5
—
—
—
0
0
46
433
1.06
0.11
1.5
1.3
—
—
—
0
0
75
774
0.96
0.10
2.1
2.0
—
—
—
0
0
68
652
1.04
0.09
1.1
1.1
—
—
—
0
0
46
478
0.95
0.08
1.2
1.3
3.71
3.01
u/ml
0.15
32
355
39
370
1.05
0.07
2.7
1.9
—
—
—
0
0
16
173
0.92
0.07
1.3
1.5
24.72
10.50
u/ml
0.25
11
121
6
72
0.83
0.07
1.0
1.0
172.50
162.60
g/l
—
6
72
7
80
0.87
0.07
1.0
1.3
—
1.55
—
0
6
25
234
1.06
0.07
1.3
1.4
—
—
—
0
0
89
907
0.97
0.07
2.5
2.2
—
—
—
0
0
18
166
1.08
0.07
1.0
1.0
3.18
3.32
kpa
0.10
11
139
8
94
0.84
0.06
1.0
1.2
—
28.01
—
0
12
10
110
0.90
0.05
1.3
1.2
—
—
—
0
0
102
1032
0.98
0.05
3.3
3.3
85.40
121.59
ug/g
1.01
81
834
26
270
0.96
0.04
1.2
1.1
7.63
8.01
u/ml
0.03
15
184
18
169
1.06
0.04
1.0
1.0
6.87
7.31
kpa
0.32
11
142
38
368
1.03
0.02
2.7
2.0
161.81
176.01
u/ml
0.12
21
179
11
107
1.02
0.00
2.7
3.0
134.18
136.97
g/l
0.18
11
89
28
274
1.02
0.00
1.4
1.3
330.14
263.71
miu/ml
0.32
11
133
14
142
0.98
0.00
1.1
1.1
—
—
—
0
0
25
247
1.01
0.00
1.1
1.1
4.08
10.21
u/ml
1.03
12
157
21
207
1.01
0.00
1.5
1.5
—
—
—
0
0
21
207
1.01
0.00
1.5
1.5
—
—
—
0
0
21
207
1.01
0.00
1.5
1.5
—
—
—
0
0
21
207
1.01
0.00
1.5
1.5
—
—
—
0
0
5
53
0.94
-0.00
3.2
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
120.50
—
0
6
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.1
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.9
—
2.75
—
0
9
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.1
—
—
—
0
0
5
57
0.87
-0.00
1.4
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
83.00
—
0
5
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
9
98
0.91
-0.00
1.0
1.2
—
44.05
—
0
6
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
54
0.92
-0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: KRA_PSY_MOTOR – Motor disorders
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).